These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND LDH AND Clinical Outcome
8 results:

  • 1. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
    Kroep JR; van Werkhoven E; Polee M; van Groeningen CJ; Beeker A; Erdkamp F; Weijl N; van Bochove A; Erjavec Z; Kapiteijn E; Stiggelbout AM; Nortier HW; Gelderblom H
    J Geriatr Oncol; 2015 Jul; 6(4):307-15. PubMed ID: 26073532
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.
    Silvestris N; Scartozzi M; Graziano G; Santini D; Lorusso V; Maiello E; Barni S; Cinieri S; Loupakis F; Pisconti S; Brunetti AE; Palasciano G; Palmieri VO; Del Prete M; Dell'Aquila E; Latiano TP; Petrelli F; Lutrino S; Rossini D; Giampieri R; Lotesoriere C; Cascinu S
    Expert Opin Biol Ther; 2015 Feb; 15(2):155-62. PubMed ID: 25411089
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The role of tiopronin for the prevention of chemotherapy-related liver toxicity in advanced colorectal cancer patients treated with mFOLFOX7: a prospective analysis.
    Li XP; Wen F; Yang W; Deng YB; Li M; Zhang PF; Tang RL; Li Q; Wei YQ
    Tumori; 2014; 100(4):446-51. PubMed ID: 25296595
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients.
    Scartozzi M; Giampieri R; Maccaroni E; Del Prete M; Faloppi L; Bianconi M; Galizia E; Loretelli C; Belvederesi L; Bittoni A; Cascinu S
    Br J Cancer; 2012 Feb; 106(5):799-804. PubMed ID: 22315053
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.
    Mekenkamp LJ; Heesterbeek KJ; Koopman M; Tol J; Teerenstra S; Venderbosch S; Punt CJ; Nagtegaal ID
    Eur J Cancer; 2012 Mar; 48(4):501-9. PubMed ID: 22226571
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Correlation between TBARS levels and glycolytic enzymes: the importance to the initial evaluation of clinical outcome of colorectal cancer patients.
    Farias IL; Farias JG; Rossato L; Araújo MC; Chiesa J; Morsh V; Schetinger MR
    Biomed Pharmacother; 2011 Sep; 65(6):395-400. PubMed ID: 21715128
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9.
    Weissenberger C; Von Plehn G; Otto F; Barke A; Momm F; Geissler M
    Anticancer Res; 2005; 25(3A):1787-93. PubMed ID: 16033101
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.